• Go to Home

About Dr. Wayman Wendell Cheatham

Dr. Cheatham was Vice-President of the Pine Forge Academy Class of 1966.

Wayman Wendell Cheatham, M.D., FACE, board certified in endocrinology and metabolism, is Special Assistant to the Surgeon General of the United States Navy for Medical Research and is Director, Navy Medicine Research & Development Center at Navy Medicine Headquarters. Dr. Cheatham’s office has policy and oversight responsibility for all of Navy Medical R&D globally.

 

With nearly 30 years of experience as a clinician and as a biochemical and medical researcher, Dr. Cheatham is a renowned pharmaceutical development and energy metabolism expert, having served as the senior executive in charge of research for one of the World’s largest pharmaceutical companies. Just prior to his current position, he served as Assistant Vice President and Medical Director of MedStar Clinical Research Centers for MedStar Research Institute in Washington, DC.

 

Dr. Cheatham is published in prominent clinical and scientific journals, including Annals of the New York Academy of Sciences, Clinical Diabetes, Diabetologia, American Journal of Clinical Nutrition and Immunological Investigations, and is highly sought after lecturer for international medical conferences and academic institutions. He is proficient in research protocol design and has led scores of research efforts. Dr. Cheatham earned a BA in Chemistry from Columbia Union College in Maryland. He earned his medical degree from the College of Medicine of The Pennsylvania State University and completed specialty training in internal medicine, and in endocrinology and metabolism at Letterman Medical Center in San Francisco and at Walter Reed Medical Center in Washington, D.C. He is a Fellow of the American College of Endocrinology, and has served in prominent leadership roles for numerous private academic institutions and professional and medical societies. He has recently completed a three year term as a member of the Board of Directors of The American Diabetes Association and currently serves as a member of their Advocacy Committee. He also is a member of the Board of Directors of the American Type Culture Collection.  Dr. Cheatham holds membership in the American Association of Clinical Endocrinologists, The Endocrine Society – where he serves as a member of the Clinical Affairs Committee and chairs the Scientific Statements Committee. He is also a member of the European Association for the Study of Diabetes and of the Society of Research Administrators – where he serves as an associate editor of their peer reviewed journal.

 

Dr. Cheatham’s current research interests include pancreatic islet function and regeneration, insulin action, insulin resistance, lipid abnormalities and the metabolic basis of vascular dysfunction.  Dr. Cheatham currently serves as Chief of Endocrinology and Metabolism and Director of the Endocrinology and Metabolism training at Howard University, Washington, DC.